Last 37 quarters of trend data · Healthcare · Healthcare Providers
Quarterly valuation ratios — annualised for comparability. YoY Δ shows same-quarter-prior-year change.
| Metric | TTM | Q3 '26 | Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 | Q3 '23 | Q2 '23 | Q1 '23 | Q4 '22 | Q3 '22 | Q2 '22 | Q1 '22 | Q4 '21 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| P/E Ratio → | -7.17 | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | |
| P/S Ratio | 0.94 | 1.07 | 0.56 | 0.73 | 0.57 | 1.23 | 1.52 | 1.77 | 0.66 | 0.31 | 0.82 | 2.01 | 1.04 | 0.54 | 0.87 | 1.31 | 2.57 | 1.30 | 1.32 | 1.42 | 1.96 |
| — | -12.8% | -63.2% | -58.6% | -13.5% | +297.0% | +84.3% | -12.2% | -36.7% | -43.1% | -5.8% | +53.4% | -59.6% | -58.1% | -33.7% | -7.6% | +31.2% | -58.4% | -82.0% | -77.6% | -42.3% | |
| P/B Ratio | 5.40 | 8.04 | 4.29 | 5.91 | 3.62 | 5.86 | 7.33 | 5.72 | 1.86 | 2.45 | 2.79 | 5.07 | 2.46 | 1.03 | 1.35 | 1.69 | 3.28 | 1.36 | 1.26 | 1.05 | 1.38 |
| — | +37.3% | -41.5% | +3.4% | +94.7% | +139.0% | +162.7% | +12.8% | -24.6% | +138.6% | +106.4% | +200.6% | -24.8% | -24.5% | +7.6% | +60.4% | +137.2% | -28.1% | -70.6% | -65.5% | -83.3% | |
| P/FCF | — | 58.66 | — | — | 34.28 | — | — | — | — | — | — | — | 16.79 | — | — | — | — | — | — | — | — |
| — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | |
| EV / EBITDA | — | 47.90 | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | |
| EV / EBIT | — | 113.59 | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
Quarterly margins and returns. Watch for margin compression across consecutive quarters.
| Metric | TTM | Q3 '26 | Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 | Q3 '23 | Q2 '23 | Q1 '23 | Q4 '22 | Q3 '22 | Q2 '22 | Q1 '22 | Q4 '21 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | 48.5% | 52.2% | 51.1% | 46.9% | 52.0% | 45.9% | 46.6% | 49.2% | 66.2% | 75.6% | 74.0% | 75.1% | 77.6% | 65.8% | 72.5% | 73.3% | 75.9% | 78.4% | 75.3% | 75.4% | 76.4% |
| — | +13.7% | +9.6% | -4.7% | -21.5% | -39.3% | -37.1% | -34.5% | -14.7% | +14.9% | +2.1% | +2.5% | +2.3% | -16.1% | -3.6% | -2.8% | -0.7% | +1.5% | -6.7% | -7.9% | +0.8% | |
| Operating Margin | -21.1% | 1.3% | -3.6% | -26.1% | -12.1% | -19.6% | -21.1% | -34.4% | -51.0% | -41.7% | -51.7% | -39.4% | -21.8% | -49.6% | -41.7% | -63.8% | -42.5% | -45.2% | -60.0% | -71.5% | -46.0% |
| — | +106.6% | +82.9% | +24.2% | +76.3% | +52.9% | +59.1% | +12.5% | -134.0% | +15.9% | -23.9% | +38.2% | +48.7% | -9.8% | +30.4% | +10.8% | +7.7% | +13.2% | -29.8% | -27.1% | -169.4% | |
| Net Margin | -26.1% | -4.0% | -8.3% | -31.3% | -17.1% | -24.3% | -26.6% | -39.6% | -56.3% | -72.0% | -59.8% | -45.2% | -26.5% | -52.5% | -27.8% | -67.7% | -45.6% | -46.1% | -63.8% | -76.4% | -50.8% |
| — | +83.4% | +68.8% | +21.0% | +69.6% | +66.3% | +55.6% | +12.3% | -112.7% | -37.1% | -114.8% | +33.2% | +41.9% | -13.9% | +56.4% | +11.4% | +10.4% | +21.9% | -20.5% | -19.2% | -116.5% |
| Metric | TTM | Q3 '26 | Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 | Q3 '23 | Q2 '23 | Q1 '23 | Q4 '22 | Q3 '22 | Q2 '22 | Q1 '22 | Q4 '21 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ROE | -134.4% | -7.7% | -17.8% | -49.8% | -24.9% | -28.8% | -28.5% | -35.5% | -61.5% | -92.8% | -41.8% | -25.5% | -14.9% | -22.5% | -10.4% | -20.0% | -13.8% | -11.6% | -14.4% | -13.4% | -8.7% |
| — | +73.3% | +37.6% | -40.2% | +59.6% | +69.0% | +31.8% | -39.6% | -312.5% | -311.9% | -300.1% | -27.6% | -8.0% | -94.4% | +27.3% | -49.0% | -59.4% | -33.7% | -90.2% | -8.4% | +37.2% | |
| ROA | -27.6% | -1.3% | -2.7% | -8.1% | -5.0% | -6.5% | -7.3% | -9.0% | -11.8% | -15.6% | -9.8% | -7.2% | -5.1% | -9.7% | -4.8% | -9.5% | -7.0% | -6.3% | -8.2% | -8.0% | -5.4% |
| — | +80.1% | +63.4% | +9.8% | +57.6% | +58.6% | +25.4% | -25.0% | -128.7% | -60.7% | -104.0% | +24.9% | +26.7% | -54.6% | +41.7% | -19.4% | -30.7% | -12.2% | -64.5% | -17.1% | -15.3% | |
| ROIC | -26.6% | 0.5% | -1.3% | -7.9% | -4.4% | -6.0% | -6.2% | -8.4% | -13.0% | -15.1% | -15.6% | -13.0% | -8.4% | -16.2% | -15.1% | -24.9% | -20.9% | -16.9% | -20.3% | -23.1% | -17.1% |
| — | +107.6% | +79.6% | +6.8% | +65.8% | +60.2% | +60.4% | +34.9% | -55.4% | +6.6% | -3.3% | +48.0% | +59.9% | +4.2% | +25.5% | -8.0% | -22.6% | +21.4% | +19.7% | +24.4% | -28.1% |
Quarterly solvency trend — watch for debt spikes or covenant pressure.
| Metric | TTM | Q3 '26 | Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 | Q3 '23 | Q2 '23 | Q1 '23 | Q4 '22 | Q3 '22 | Q2 '22 | Q1 '22 | Q4 '21 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debt / Equity | 3.44 | 3.92 | 4.00 | 5.01 | 3.44 | 2.89 | 2.56 | 2.09 | 2.60 | 5.19 | 3.23 | 2.26 | 1.83 | 1.06 | 0.88 | 0.83 | 0.70 | 0.63 | 0.58 | 0.52 | 0.46 |
| — | +35.3% | +56.2% | +139.7% | +32.4% | -44.3% | -20.8% | -7.6% | +42.2% | +390.0% | +265.3% | +171.1% | +162.3% | +68.2% | +52.7% | +61.3% | +50.0% | +48.9% | +46.2% | +37.1% | -69.1% | |
| Debt / EBITDA | — | 68.38 | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | |
| Current Ratio | 2.02 | 2.01 | 1.88 | 1.67 | 2.02 | 2.24 | 2.02 | 2.44 | 1.86 | 3.16 | 2.58 | 5.65 | 4.73 | 4.63 | 5.17 | 5.36 | 2.98 | 4.02 | 5.02 | 7.82 | 7.34 |
| — | -10.5% | -6.9% | -31.7% | +8.5% | -29.1% | -21.8% | -56.7% | -60.7% | -31.7% | -50.1% | +5.3% | +59.1% | +15.2% | +3.0% | -31.5% | -59.5% | +60.9% | -56.9% | -38.6% | +54.6% | |
| Quick Ratio | 1.87 | 1.82 | 1.69 | 1.50 | 1.87 | 2.09 | 1.84 | 2.28 | 1.72 | 2.87 | 2.37 | 5.18 | 4.33 | 4.00 | 4.58 | 4.76 | 2.71 | 3.68 | 4.64 | 7.25 | 6.93 |
| — | -12.9% | -8.4% | -34.1% | +8.8% | -27.1% | -22.3% | -56.1% | -60.2% | -28.2% | -48.2% | +9.0% | +59.8% | +8.6% | -1.3% | -34.4% | -60.9% | +54.2% | -58.5% | -40.8% | +54.6% | |
| Interest Coverage | -3.63 | 0.25 | -0.93 | -3.76 | -2.42 | -3.52 | -4.10 | -5.60 | -6.95 | -6.73 | -3.97 | -3.31 | -2.24 | -6.93 | -3.28 | -7.40 | -8.81 | -6.17 | -9.42 | -10.08 | -9.28 |
| — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
Includes 30+ ratios · 37 years · Updated daily
Live VCP patterns, Cup & Handle overlays, support/resistance, and AI trade plans.
High-probability breakout stocks crossing their pivot across 5 pattern engines.
DCF models, multiple analysis, and analyst estimates.
10-year return with dividends reinvested.
Compare growth, multiples, and margins vs sector.
Quick answers to the most common questions about buying STIM stock.
Neuronetics, Inc.'s current P/E is -7.2x. Quarterly P/E ratios can vary due to seasonal revenue patterns and one-time charges.
Neuronetics, Inc.'s current operating margin is -21.1%. Margins have been expanding over recent quarters. Quarterly margins are particularly useful for identifying trend inflections that annual data smooths over.
Quarterly financial ratios reveal short-term trend shifts — margin compression, debt spikes, or valuation re-ratings — that annual figures smooth over. They're essential for active investors tracking Neuronetics, Inc.'s business trajectory between earnings reports.